Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK
- 23 June 2020
- journal article
- letter
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 91 (10), 1126-1128
- https://doi.org/10.1136/jnnp-2020-323158
Abstract
No abstract availableFunding Information
- We gratefully acknowledge the Highly Specialised Commissioning Team of the National Health Service for funding the Neuromyelitis Optica service in Oxford.
This publication has 13 references indexed in Scilit:
- A population‐based epidemiological study of neuromyelitis optica spectrum disorder in HungaryEuropean Journal of Neurology, 2019
- The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adultsMultiple Sclerosis Journal, 2019
- Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in DenmarkNeurology, 2018
- Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimatesMultiple Sclerosis Journal, 2017
- Incidence and prevalence of NMOSD in Australia and New ZealandJournal of Neurology, Neurosurgery & Psychiatry, 2017
- International consensus diagnostic criteria for neuromyelitis optica spectrum disordersNeurology, 2015
- MOG cell-based assay detects non-MS patients with inflammatory neurologic diseaseNeurology Neuroimmunology & Neuroinflammation, 2015
- The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United KingdomZeitschrift für Neurologie, 2013
- Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotypeNeurology, 2012
- The prevalence of neuromyelitis optica in South East WalesEuropean Journal of Neurology, 2011